Schedule 13D ownership disclosure

Mirum Pharmaceuticals Inc

Security class unavailable · CUSIP: 604749101

Event date: 2022-08-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-209968
Form type
SC 13D/A
Filer
Mirum Pharmaceuticals, Inc.
CIK
CIK 1759425
Filed
Aug 02, 2022
Reporting period
Aug 01, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub